Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuancesWages, Salaries and Other
Ratios

Coeptis Therapeutics Holdings (COEP) Leases (2021 - 2025)

Historic Leases for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to $29104.0.

  • Coeptis Therapeutics Holdings' Leases fell 5815.63% to $29104.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $29104.0, marking a year-over-year decrease of 5815.63%. This contributed to the annual value of $59783.0 for FY2024, which is 3872.87% down from last year.
  • According to the latest figures from Q3 2025, Coeptis Therapeutics Holdings' Leases is $29104.0, which was down 5815.63% from $39564.0 recorded in Q2 2025.
  • Coeptis Therapeutics Holdings' Leases' 5-year high stood at $97571.0 during Q4 2023, with a 5-year trough of $17925.0 in Q4 2021.
  • For the 5-year period, Coeptis Therapeutics Holdings' Leases averaged around $49892.9, with its median value being $49427.0 (2023).
  • Per our database at Business Quant, Coeptis Therapeutics Holdings' Leases surged by 22866.95% in 2022 and then crashed by 5815.63% in 2025.
  • Coeptis Therapeutics Holdings' Leases (Quarter) stood at $17925.0 in 2021, then surged by 228.67% to $58914.0 in 2022, then surged by 65.62% to $97571.0 in 2023, then crashed by 38.73% to $59783.0 in 2024, then crashed by 51.32% to $29104.0 in 2025.
  • Its last three reported values are $29104.0 in Q3 2025, $39564.0 for Q2 2025, and $49789.0 during Q1 2025.